RSPH9 Gene Primary Ciliary Dyskinesia Type 12 NGS Genetic DNA Test
Introduction
The RSPH9 Gene Primary Ciliary Dyskinesia Type 12 NGS Genetic DNA Test is a cutting-edge diagnostic tool designed to identify genetic mutations associated with primary ciliary dyskinesia (PCD). This condition affects the cilia, the tiny hair-like structures that line the respiratory tract, leading to severe respiratory issues and increased susceptibility to infections. Early diagnosis through this genetic test is crucial for effective management of the condition.
What the Test Measures
This genetic test specifically analyzes the RSPH9 gene to detect mutations that may lead to primary ciliary dyskinesia type 12. Understanding these genetic variations helps in confirming a diagnosis and guiding treatment options.
Who Should Consider This Test
Individuals exhibiting symptoms such as chronic respiratory infections, sinusitis, or unexplained fertility issues should consider this test. Additionally, those with a family history of PCD or related symptoms should seek genetic testing for a comprehensive evaluation.
Benefits of Taking the Test
- Early detection of genetic disorders related to respiratory function.
- Informed decision-making regarding treatment options.
- Potential for improved health outcomes and quality of life.
- Guidance for family planning and understanding hereditary risks.
Understanding Your Results
Results from the RSPH9 Gene Primary Ciliary Dyskinesia Type 12 NGS Genetic DNA Test will be provided in a detailed report. A genetic counselor will assist in interpreting the results, helping you understand the implications for your health and your family.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| RSPH9 Gene Primary Ciliary Dyskinesia Type 12 NGS Genetic DNA Test | 40,000 KSh | 56,000 KSh |
Book Your Test Today!
We have branches across Kenya and offer a convenient home sample collection service. To book the RSPH9 Gene Primary Ciliary Dyskinesia Type 12 NGS Genetic DNA Test, call or WhatsApp us at +254711564616.
Turnaround time for results is approximately 3 to 4 weeks. Sample types accepted include blood, extracted DNA, or one drop of blood on an FTA card. Please ensure you have a clinical history ready for review prior to testing.
